Trial Profile
Study on the regimen of neohuoxin (recombinant human BNP) sequential sacubatril/valsartan (LCZ696) in the treatment of acute heart failure
Status:
Completed
Phase of Trial:
Phase IV
Latest Information Update: 18 May 2021
Price :
$35
*
At a glance
- Drugs Sacubitril/valsartan (Primary) ; ACE inhibitors; Beta-adrenergic receptor antagonists; Steroid receptor antagonists
- Indications Acute heart failure
- Focus Therapeutic Use
- 23 Apr 2021 Status changed from not yet recruiting to completed, as per results published in the Medicine.
- 23 Apr 2021 Results published in the Medicine
- 16 Apr 2018 New trial record